Last reviewed · How we verify
Memorial Healthcare System — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Cathflo Activase | Cathflo Activase | marketed | ||||
| Talc Slurry Pleurodesis | Talc Slurry Pleurodesis | marketed | Sclerosing agent | Oncology / Pulmonology |
Therapeutic area mix
- Oncology / Pulmonology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Boston Scientific Corporation · 1 shared drug class
- Chinese University of Hong Kong · 1 shared drug class
- Gulab Devi Hospital · 1 shared drug class
- Imperial College London · 1 shared drug class
- Medical University of Vienna · 1 shared drug class
- UPECLIN HC FM Botucatu Unesp · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Memorial Healthcare System:
- Memorial Healthcare System pipeline updates — RSS
- Memorial Healthcare System pipeline updates — Atom
- Memorial Healthcare System pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Memorial Healthcare System — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/memorial-healthcare-system. Accessed 2026-05-16.